Klebsiella PneumoniaeNCT07841288
Prevelance of Klebsiella Pneumonie in the Respiratory ICU
An observational study of Klebsiella Pneumoniae, run by Sohag University at 1 site in Egypt.
Trial summary
This observational study aims to determine the prevalence of Klebsiella pneumoniae isolates among respiratory specimens collected from adult patients admitted to the Respiratory Intensive Care Unit at Sohag University Hospital, and to describe their antimicrobial resistance profiles and associated clinical and… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Klebsiella Pneumoniae
- How many people
- 100 participants
- Where
- 1 siteEgypt
- Study dates
- 25 Jun 2026to Jun 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patients aged 18 years or older admitted to the Respiratory Intensive Care Unit at Sohag University Hospital, with Klebsiella pneumoniae isolated from respiratory specimens.
Inclusion Criteria:Age ≥ 18 years Patients admitted to the Respiratory Intensive Care Unit Patients with Klebsiella pneumoniae isolated from respiratory specimens -
Exclusion Criteria:Age < 18 years Patients with other Gram-negative Enterobacteriaceae isolates
-
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Egypt1 site, 1 recruiting
- Recruiting
Sohag University Hospital
Sohag
Dr mohamed Nasreldin Hamdoun, 0934602963, ethics@med.sohag.edu.eg
About this study
Official title: Prevelance of Klebsiella Pneumonie Isolates in the Respiratory Intensive Care Unit at Sohag University Hospitals
This observational study aims to determine the prevalence of Klebsiella pneumoniae isolates among respiratory specimens collected from adult patients admitted to the Respiratory Intensive Care Unit at Sohag University Hospital, and to describe their antimicrobial resistance profiles and associated clinical and epidemiological characteristics
- Conditions
- Klebsiella Pneumoniae
- Being tested
- No intervention (observational study)
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No intervention (observational study)Other
no intervention
What is being measured
The primary outcome is the main question the study is designed to answer.
prevelance of klebsiella pneumoniae isolates
prevalence/isolation rate of klebsiella pneumoniae among respiratory specimens collected from adult patients admitted to the respiratory intensive care at sohag university hospital
Measured: from june 2026 to june 2027
Secondary outcomes (2)
Antimicrobial Resistance profile of klebsiella pneumoniae isolates
Antimicrobial susceptibility patterns of Klebsiella pneumoniae isolates will be assessed separately for each tested antimicrobial agent based on antimicrobial susceptibility testing results.
Measured: from June 2026 to June 2027
Clinical and Epidemiological characteristics of patients with klebsiella pneumoniae isolation
Clinical and epidemiological characteristics including age, underlying illness, mechanical ventilation, and duration of intensive care unit stay.
Measured: from June 2026 to June 2027
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Sep 2026
- Study start25 Jun 2026
- Primary completionJun 2027 (estimated)
- Study completionJun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Klebsiella PneumoniaeStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Esraa Fatouh Ahmed, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07841288
- Sponsor's protocol ID
- Soh-Med-26-6-4MS
- Status last verified
- Sep 2026
- First submitted
- 15 Sep 2026
- Last updated
- 2 Oct 2026
- Results posted
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 2 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevelance of Klebsiella Pneumonie Isolates in the Respiratory Intensive Care Unit at Sohag University Hospitals
- ClinicalTrials.gov ID
- NCT07841288
- Acronym / sponsor ID
- Soh-Med-26-6-4MS
- Conditions
- Klebsiella Pneumoniae
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 25 Jun 2026 (actual)
- Primary completion
- Jun 2027 (estimated)
- Study completion
- Jun 2027 (estimated)
- First posted
- 25 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This observational study aims to determine the prevalence of Klebsiella pneumoniae isolates among respiratory specimens collected from adult patients admitted to the Respiratory Intensive Care Unit at Sohag University Hospital, and to describe their antimicrobial resistance profiles and associated clinical and epidemiological characteristics
Study design
- Observational model
- Other
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patients aged 18 years or older admitted to the Respiratory Intensive Care Unit at Sohag University Hospital, with Klebsiella pneumoniae isolated from respiratory specimens.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No intervention (observational study)no intervention | Other | – |
Primary outcome
prevelance of klebsiella pneumoniae isolates
Time frame: from june 2026 to june 2027
prevalence/isolation rate of klebsiella pneumoniae among respiratory specimens collected from adult patients admitted to the respiratory intensive care at sohag university hospital
2 secondary outcomes
Antimicrobial Resistance profile of klebsiella pneumoniae isolates
Time frame: from June 2026 to June 2027
Clinical and Epidemiological characteristics of patients with klebsiella pneumoniae isolation
Time frame: from June 2026 to June 2027
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Oct 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Klebsiella Pneumoniae
RecruitingPhase 4
CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients
Severe Infection
RecruitingObservational study
Epidemiology and Overtime Genomic Evolution of Klebsiella Pneumoniae and Enterobacter Cloacae Complex (ECC) in Stools of ICU's Patients
Longitudinal, Genomic Stability
Not yet recruitingObservational study
Ceftazidime-Avibactam PK/PD and Resistance in Hematology Patients
Hematologic Neoplasms, Gram-Negative Bacterial Infections
Not yet recruitingObservational study
Outer Membrane Vesicle and Ferroptosis-Related Signatures in Sepsis-Associated Acute Lung Injury Caused by Extra-Pulmonary Hypervirulent Klebsiella Pneumoniae
Sepsis, Acute Lung Injury(ALI)
RecruitingObservational study
Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital
Infections With CPB
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Klebsiella Pneumoniae, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
prevelance of klebsiella pneumoniae isolates (time frame: from june 2026 to june 2027). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2026.